CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer

Medullary thyroid cancer (MTC) is a rare malignancy, and the treatment of metastatic MTC is challenging. In previous work, immune profiling (RNA-Seq) of MTC identified CD276 as a potential target for immunotherapy. CD276 expression was 3-fold higher in MTC cells than in normal tissues. Paraffin bloc...

Descripción completa

Detalles Bibliográficos
Autores principales: Hińcza-Nowak, Kinga, Kowalik, Artur, Walczyk, Agnieszka, Pałyga, Iwona, Gąsior-Perczak, Danuta, Płusa, Agnieszka, Kopczyński, Janusz, Chrapek, Magdalena, Góźdź, Stanisław, Kowalska, Aldona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298428/
https://www.ncbi.nlm.nih.gov/pubmed/37373167
http://dx.doi.org/10.3390/ijms241210019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298428/
https://www.ncbi.nlm.nih.gov/pubmed/37373167
http://dx.doi.org/10.3390/ijms241210019

Ejemplares similares